← SynDRA
PENTAGASTRIN
SynDRA canonical compound SYN0005315 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Approval status | Approved · OTC |
|---|
| Primary target(s) | CCKBR |
|---|
| Mechanism of action | CCK receptor agonist |
|---|
| Indication | anacidity diagnostic | gastric hypersecretion diagnostic |
|---|
| Disease area | gastroenterology |
|---|
All known targets
Mechanisms of action (all sources)
- CCK receptor agonist
- CCKBR AGONIST
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ADORA1
- NR3C1
- HTR2B
- HTR2C
- HTR3A
- KCNH2
- MAOA
- MC3R
- MC4R
- MLNR
- NPY1R
- NR1I2
- OPRD1
- ADORA2A
- OPRK1
- OPRM1
- PDE3A
- PDE4D
- PGR
- PTGS2
- SLC29A1
- SLC6A2
- SLC6A3
- SLC6A4
- HTR2A
- HTR1A
- HRH2
- HRH1
- ADORA3
- ADRA1A
- ADRA2A
- ADRA2B
- ADRA2C
- ADRB1
- ADRB2
- AGTR1
- AVPR1A
- AVPR2
- BDKRB2
- CHRM1
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
ATC classes
- V04C · OTHER DIAGNOSTIC AGENTS
Cross-references
Synonyms
- PEPTAVLON
- pentavlon
- peptavlon
- ICI 50123
- Pentagastrine
- Pentagastrina
- AY-6608
- ICI 50,123
- ICI-50123
- NSC-367746
- Peptavlon
- Peptavlon (TN)
- Pentagastrin (JAN/USAN/INN)
- AY 6608
- CHEMBL1328
- EF0NX91490
- NSC 367746
- Gastrodiagnost
- Pentagastrinum
- Petogasrin
- CAS-5534-95-2
- Pentagastrine [INN-French]
- Pentagastrinum [INN-Latin]
- Pentagastrina [INN-Spanish]
- UNII-EF0NX91490
- HSDB 3247
- Boc-beta-ala-try-met-asp-phe(nh2)
- EINECS 226-889-7
- Pentagastrin [USAN:INN:BAN:JAN]
- MFCD00076515
- BRN 5472892
- PENTAGASTRIN [MI]
- PENTAGASTRIN [INN]
- PENTAGASTRIN [JAN]
- PENTAGASTRIN [HSDB]
- PENTAGASTRIN [USAN]
- PENTAGASTRIN [VANDF]
- SCHEMBL26045
Look up PENTAGASTRIN in the interactive SynDRA portal →